Abstract:Objective To investigate the relationship of chemotherapy-related cognitive impairment and cancer-related fatigue with quality of life in elderly patients with non-Hodgkin lymphoma at different stages. Methods A cross-sectional study was conducted on 350 elderly patients with non-Hodgkin lymphoma admitted to the First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People′s Hospital) from August 2023 to May 2024. They were grouped according to disease stage. Because of the small number of stage Ⅳ patients, stage Ⅲ and Ⅳ patients were included in one group, resulting in stage Ⅰ group, stage Ⅱ group, and stage Ⅲ-Ⅳ group. The Chinese version of the functional assessment of cancer therapy-cognitive function (FACT-Cog) was used to assess chemotherapy-related cognitive impairment, the cancer fatigue scale (CFS) was used to assess the degree of cancer-related fatigue, and the quality of life questionnaire (QLQ-C30) was used to assess the patients′ quality of life. Pearson correlation analysis was used to analyze the correlation of chemotherapy-related cognitive impairment with cancer-related fatigue and quality of life in elderly patients with non-Hodgkin lymphoma. SPSS 20.0 was used for statistical analysis. Data comparison between two groups was performed using t test, F test orχ2 test depending on data type. Results Patients at different disease stages had statistically significant differences in perceived cognitive impairment, impact on quality of life, evaluation of others, cognitive function scores, and total scores (F=116.472,246.146,282.293,191.500,231.825; P<0.05). There were statistically significant differences in the score of physical fatigue, affection and cognition, and total scores among patients at different disease stages (F=369.548,101.615,97.400,370.149; P<0.05). There were statistically significant differences in scores of emotional function, role function, cognitive function, social function and physical function scores, and total scores among patients at different disease stages (F=80.100,80.106,52.536,60.791,91.967,75.300; P<0.05). Chemotherapy-related cognitive impairment in elderly patients with non-Hodgkin lymphoma was significantly positively correlated with cancer-related fatigue (r=0.571, P<0.05) and negatively correlated with quality of life (r=-0.360, P<0.05), and cancer-related fatigue was significantly negatively correlated with quality of life (r=-0.376, P<0.05). Chemotherapy-related cognitive impairment and cancer-related fatigue were positively correlated with disease stage (r=0.751,0.781; P<0.05), while quality of life was negatively correlated with disease stage (r=-0.497, P<0.05). Conclusion Chemotherapy-related cognitive impairment and cancer-related fatigue are significantly correlated with quality of life of elderly patients, particularly among those at different disease stages. This finding emphasizes the importance of comprehensive assessment of elderly patients with non-Hodgkin′s lymphoma, suggesting that clinicians should comprehensively consider cognitive function and fatigue when formulating treatment regimens to optimize patients′ quality of life.